Full Text View
Tabular View
Study Results
Related Studies
Healozone Study to Evaluate the Safety and Efficacy of the Use of Ozone for Management of Dental Caries
This study has been completed.
Study NCT00495495   Information provided by Indiana University School of Dentistry

First Received on July 1, 2007.   Last Updated on January 5, 2011   History of Changes
Results First Received: October 12, 2010  
Study Type: Interventional
Study Design: Allocation: Randomized;   Endpoint Classification: Safety/Efficacy Study;   Intervention Model: Parallel Assignment;   Masking: Double Blind (Subject, Outcomes Assessor);   Primary Purpose: Prevention
Condition: Dental Caries
Interventions: Device: Ozone treatment
Device: Placebo treatment

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Ozone Treatment and Placebo Treatment 60-second Ozone device treatment compared to 60-second Placebo device treatment. Study utilized split-mouth design. The paired treatment assignment for the two teeth within each subject was performed according to a randomization table provided by the Biometrician. Randomization of teeth to Ozone treatment or Placebo treatment was stratifed according to tooth similarity.

Participant Flow:   Overall Study
    Ozone Treatment and Placebo Treatment  
STARTED     394  
COMPLETED     295  
NOT COMPLETED     99  
Protocol Violation                 99  



  Baseline Characteristics
  Hide Baseline Characteristics

Reporting Groups
  Description
Ozone Treatment/Placebo Treatment Study utilized split-mouth design. Each participant had two teeth selected at the start of the study. Each participant was then randomized to receive Ozone treatment on a randomly selected study tooth for 60 seconds and Placebo treatment on a randomly selected study tooth for 60 seconds.

Baseline Measures
    Ozone Treatment/Placebo Treatment  
Number of Participants  
[units: participants]
  394  
Age  
[units: participants]
 
<=18 years     102  
Between 18 and 65 years     292  
>=65 years     0  
Age  
[units: years]
Mean ± Standard Deviation
  22.9  ± 7.2  
Gender  
[units: participants]
 
Female     202  
Male     192  
Region of Enrollment  
[units: participants]
 
United States     394  



  Outcome Measures
  Show All Outcome Measures

1.  Primary:   ICDAS Severity Value   [ Time Frame: Baseline and One Year ]

2.  Secondary:   Change in Caries Lesion Activity   [ Time Frame: Baseline and one year ]

3.  Secondary:   Progression of Radiographic Scores at 12 Months   [ Time Frame: one year ]

4.  Secondary:   Laser Fluorescence Progression-12 Month (Increase From <=20 to >=30)   [ Time Frame: one year ]

5.  Secondary:   Laser Fluorescence Progression-12 Month (Increase at Least 10)   [ Time Frame: one year ]


  Serious Adverse Events
  Show Serious Adverse Events


  Other Adverse Events
  Show Other Adverse Events


  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.


Limitations and Caveats
Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
Study length may have been too brief to permit progression of early stage caries; Low caries increment in study population; Difficult to establish that lesions were truly active at baseline.  


Results Point of Contact:  
Name/Title: Domenick T. Zero, DDS MS Principal Investigator
Organization: Indiana University School of Dentistry
phone: 317-274-8822
e-mail: dzero@iupui.edu


No publications provided


Responsible Party: Dr. Domenick Zero, Indiana University School of Dentistry
ClinicalTrials.gov Identifier: NCT00495495     History of Changes
Other Study ID Numbers: 07-D-187, IDE G50008, Clinical Trials. gov
Study First Received: July 1, 2007
Results First Received: October 12, 2010
Last Updated: January 5, 2011
Health Authority: United States: Food and Drug Administration